Lv1
60 积分 2025-11-17 加入
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
4天前
已完结
[Chinese expert consensus on clinical diagnosis and treatment of pelvic venous leiomyomatosis]
5个月前
已完结
皖公网安备34019202002308
